
BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260116
DTEND;VALUE=DATE:20260118
DTSTAMP:20260507T232807
CREATED:20251124T213453Z
LAST-MODIFIED:20251124T213510Z
UID:10000400-1768521600-1768694399@oncodaily.com
SUMMARY:ESMO Preceptorship on Breast Cancer 2026: Milan
DESCRIPTION:The ESMO Preceptorship on Breast Cancer 2026: Milan is a two-day educational course that provides oncologists with a thorough understanding of breast cancer management\, covering topics from diagnosis to treatment\, based on current standards of care in a multidisciplinary setting. \nThe preceptorship will take place from January 16–17\, 2026\, in Milan\, Italy. The course is accredited with ESMO-MORA category 1 points\, and the application deadline for attendance is November 25\, 2025. \nApply.
URL:https://oncodaily.com/event/preceptorship-on-breast-cancer-415828
LOCATION:Milan\, Italy
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/16_9-2.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260121
DTEND;VALUE=DATE:20260122
DTSTAMP:20260507T232807
CREATED:20260120T144735Z
LAST-MODIFIED:20260120T144743Z
UID:10000602-1768953600-1769039999@oncodaily.com
SUMMARY:ESMO Therapeutic Landscapes: Toxicity of Cellular Therapies 2026
DESCRIPTION:The ESMO webinar “Therapeutic Landscapes: Toxicity of Cellular Therapies 2026“ is a specialized virtual educational session scheduled for January 21\, 2026\, at 18:30 CET. \nLed by chairs and speakers Claire Roddie\, Marco Donia\, and Changsong Qi\, the program focuses on the recognition and management of unique complications arising from advanced cancer treatments\, specifically CAR-T and TIL-based adoptive cell therapies. Key topics include the clinical presentation of cytokine release syndrome (CRS)\, immune effector cell-associated neurotoxicity syndrome (ICANS)\, and emerging toxicities associated with tumor-infiltrating lymphocytes. \nRegister.
URL:https://oncodaily.com/event/toxicity-of-cellular-therapies-444070
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260124
DTEND;VALUE=DATE:20260125
DTSTAMP:20260507T232807
CREATED:20251227T142759Z
LAST-MODIFIED:20251227T142830Z
UID:10000534-1769212800-1769299199@oncodaily.com
SUMMARY:ESMO Advanced Course on CDK4/6 Inhibitors in Breast Cancer Management 2026: Jeddah
DESCRIPTION:The ESMO Advanced Course on CDK4/6 Inhibitors in Breast Cancer Management 2026 is an intensive\, single-day educational symposium scheduled for January 24\, 2026\, in Jeddah\, Saudi Arabia. \nOrganized by the European Society for Medical Oncology (ESMO)\, this event is designed as a closed course specifically for invited medical oncologists and oncology fellows from the Middle East. The program focuses on the biological function of CDK4/6 in breast cancer and the practical integration of CDK4/6 inhibitors into the treatment landscape for both early-stage and metastatic hormone receptor-positive (HR+) / HER2-negative breast cancer.
URL:https://oncodaily.com/event/breast-cancer-management-434682
LOCATION:Jeddah\, Saudi Arabia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-2.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260128
DTEND;VALUE=DATE:20260129
DTSTAMP:20260507T232807
CREATED:20251126T001040Z
LAST-MODIFIED:20251126T001052Z
UID:10000401-1769558400-1769644799@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Colorectal Cancer 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Colorectal Cancer 2026 is a live virtual event focused on discussing real-world clinical cases and applying ESMO guidelines to the management of colorectal cancer. This webinar is scheduled to take place virtually on January 28\, 2026\, at 18:30 CET (Central European Time). \nRegister.
URL:https://oncodaily.com/event/real-world-cases-416464
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/esmo.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260131
DTEND;VALUE=DATE:20260201
DTSTAMP:20260507T232807
CREATED:20251227T143844Z
LAST-MODIFIED:20251227T143852Z
UID:10000535-1769817600-1769903999@oncodaily.com
SUMMARY:ESMO in Focus Immuno-Oncology Bulgaria 2026
DESCRIPTION:The ESMO in Focus Immuno-Oncology Bulgaria 2026 is a licensed scientific conference organized by the Bulgarian Scientific Society for Immuno-Oncology (BSIO) in collaboration with the European Society for Medical Oncology (ESMO). \nScheduled for January 31\, 2026\, in Sofia\, the meeting serves as a regional forum to disseminate the latest clinical data and therapeutic breakthroughs presented at the ESMO Immuno-Oncology Congress 2025 held in London. The technical program focuses on the evolution of personalized immunotherapy\, emerging biomarkers for checkpoint inhibitor response\, and the clinical management of immune-related adverse events across various solid tumors. \nRegister.
URL:https://oncodaily.com/event/esmo-in-focus-434690
LOCATION:InterContinental Sofia\, 4 Narodno Sabranie Square\, Sofia\, Sofia City\, 1000\, Bulgaria
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-Bulgaria.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
END:VCALENDAR